4.6 Review

Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Combining European and US risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study

Roxane de La Harpe et al.

Summary: This study aimed to determine whether using polygenic risk scores improves the prediction of atherosclerotic cardiovascular disease risk when combined with clinical scores. The results showed that combining a polygenic risk score with clinical risk scores significantly improved risk reclassification for patients with intermediate risk for cardiovascular disease.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Review Medicine, General & Internal

Genetic and molecular architecture of familial hypercholesterolemia

Marianne Abifadel et al.

Summary: Atherosclerotic cardiovascular disease is a major cause of death worldwide, and familial hypercholesterolemia (FH) is a commonly inherited disease with significant risks. Advances in genetic research have greatly improved the diagnosis and treatment of FH, providing more therapeutic options.

JOURNAL OF INTERNAL MEDICINE (2023)

Article Medicine, General & Internal

Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011-18

Xiaopeng Liang et al.

Summary: This study aimed to estimate the prevalence of metabolic syndrome (MetS) in the US National Health and Nutrition Examination Survey (NHANES) 2011-18. The results showed that the overall prevalence of MetS increased during 2011-18, especially in participants with low educational attainment. Therefore, lifestyle modification is needed to prevent MetS and the associated risks of diabetes and cardiovascular disease.

POSTGRADUATE MEDICAL JOURNAL (2023)

Review Biochemistry & Molecular Biology

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

Gracia Fahed et al.

Summary: Metabolic syndrome is a cluster of metabolic dysregulations associated with insulin resistance and chronic low-grade inflammation. If left untreated, it significantly increases the risk of developing diabetes and cardiovascular diseases. However, many aspects of Metabolic syndrome are still not completely understood, and many questions remain unanswered. This review provides a comprehensive overview of the historical background, epidemiology, histopathology, pathophysiology, management, and prevention of Metabolic syndrome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency

Cecilia Vitali et al.

Summary: This article systematically reviews the natural history and biomarkers of LCAT deficiency in order to guide the development of novel therapeutics. The study found that fish-eye disease and familial LCAT deficiency are characterized by early corneal opacity and markedly reduced HDL-C levels. In familial LCAT deficiency, proteinuria/hematuria are the first signs of renal impairment, followed by rapid decline of renal function. LCAT activity and the percentage of circulating esterified cholesterol (EC%) are the best discriminators between these two syndromes.

JOURNAL OF LIPID RESEARCH (2022)

Review Cardiac & Cardiovascular Systems

Apolipoproteins in vascular biology and atherosclerotic disease

Anurag Mehta et al.

Summary: Apolipoproteins are vital structural components of plasma lipoproteins that influence vascular biology and atherosclerotic disease by regulating lipoprotein metabolism. Different types of apolipoproteins play different roles in lipid metabolism and atherogenesis.

NATURE REVIEWS CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis

Adam Kramer et al.

Summary: This study aimed to assess the prevalence and age-of-onset of major adverse cardiovascular events (MACE) among patients with Homozygous Familial Hypercholesterolaemia (HoFH). The findings showed that atherosclerotic cardiovascular disease is common among HoFH patients and occurs at a young age. The age-of-onset of myocardial infarction was delayed by more than a decade from pre-1990 to post-1990, reflecting substantial progress in the management of this rare but severe disorder.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist

Matthew J. Belanger et al.

Summary: Genetic testing for cardiovascular disease has greatly impacted the diagnosis and evaluation of monogenic causes of the disease. There has been increasing interest in using genetic information for risk assessment of more common diseases, such as atherosclerotic cardiovascular disease (ASCVD). Polygenic risk scores (PRS) have been developed to assess the risk of coronary artery disease and have shown a strong association in population studies. However, the added value of PRS to existing clinical risk prediction models remains a topic of debate.

CARDIOLOGY IN REVIEW (2022)

Article Cardiac & Cardiovascular Systems

Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report

Siqin Feng et al.

Summary: This case report describes a Chinese girl who was diagnosed with both autosomal recessive familial hypercholesterolemia (ARH) and membranous nephropathy (MN) carrying a novel pathogenic mutation of the LDLRAP1 gene (NM_015627: c.383 T>G, p.V128G).

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea

Han Song et al.

Summary: Polygenic risk score (PRS) for metabolic disease can independently predict the risk of atherosclerotic cardiovascular disease (ASCVD) and identify individuals at genetically high risk for ASCVD.

ATHEROSCLEROSIS (2022)

Review Genetics & Heredity

Big Data Approaches for Prevention of the Metabolic Syndrome

Xinping Jiang et al.

Summary: Metabolic syndrome is a disease characterized by multiple metabolic disorders, and its global prevalence has reached pandemic levels. In recent years, a large amount of big data research has been generated using various techniques, which can be used to prevent metabolic syndrome in advance and improve preventive strategies.

FRONTIERS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

Pleiotropic Effects of APOB Variants on Lipid Profiles, Metabolic Syndrome, and the Risk of Diabetes Mellitus

Shih-Jung Jang et al.

Summary: This study found that APOB locus variants are independently associated with lipid levels and metabolic syndrome in Taiwanese individuals. Mendelian randomization analyses supported the association of APOB variants with the risk of diabetes mellitus through their associations with LDL cholesterol levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Public, Environmental & Occupational Health

Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices

Nuntakorn Thongtang et al.

Summary: Dyslipidemia is a risk factor for cardiovascular diseases and the guidelines for its management vary by region. Primary care practitioners play a crucial role in the early detection and prevention of dyslipidemia. This paper reviews international and regional guidelines and proposes best practices for managing dyslipidemia in the Asian context.

PREVENTIVE MEDICINE REPORTS (2022)

Review Biochemistry & Molecular Biology

Genetics of Cholesterol-Related Genes in Metabolic Syndrome: A Review of Current Evidence

Sok Kuan Wong et al.

Summary: Metabolic syndrome is a cluster of metabolic dysregulations, including insulin resistance, obesity, hypertension, and dyslipidemia. This review summarizes the genetic information of cholesterol-related genes in metabolic syndrome, which may potentially serve as biomarkers for early prevention and management of the syndrome.

BIOMEDICINES (2022)

Editorial Material Chemistry, Multidisciplinary

Searching for Better Biomarkers for Metabolic Syndrome

Jyoti Madhusoodanan

ACS CENTRAL SCIENCE (2022)

Article Endocrinology & Metabolism

Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes

Wei Wang et al.

Summary: The study found that there is a strong association between MetS and novel pro-inflammatory indicators such as monocyte-to-high-density lipoprotein and monocyte-to-apolipoprotein A1 ratios. These markers may be useful for identifying MetS in newly diagnosed T2DM patients in China.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Genetics & Heredity

A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia

Christopher A. Simeone et al.

Summary: Mutations in the ADIPOQ gene can lead to reduced levels of adiponectin and increased levels of long-chain ceramides, which are associated with the development of diabetes and end-stage renal disease.

NPJ GENOMIC MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects

Yani Yu et al.

Summary: The risk of cardiovascular events and death is increased in patients with familial hypercholesterolemia (FH), especially in those with acute coronary syndrome (ACS). The Dutch Lipid Network criteria (DLCN) with a score of GE; 6 points is recommended for clinical diagnosis of FH. ACS patients with FH have an increased risk of long-term and short-term cardiovascular events and death.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Nutrition & Dietetics

A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study

Juan F. Alcala-Diaz et al.

Summary: This study found that the genetic variant rs964184 in the ZPR1 gene is associated with blood lipid levels and the risk of coronary artery disease. The type of diet can modulate this association, with a low-fat diet being more effective in regulating postprandial triglyceride levels in coronary artery disease patients compared to a Mediterranean diet.

FRONTIERS IN NUTRITION (2022)

Review Biology

Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?

Lacramioara Ionela Butnariu et al.

Summary: This review presents the genetic factors involved in the etiology of coronary artery disease (CAD) and their relationship to the disease mechanisms. The complexity and multifactorial nature of CAD's etiology have been revealed through genomic analysis, offering new perspectives on treatment.

LIFE-BASEL (2022)

Article Medicine, General & Internal

Metabolic syndrome - a new definition and management guidelines

Piotr Dobrowolski et al.

ARCHIVES OF MEDICAL SCIENCE (2022)

Article Multidisciplinary Sciences

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia

Zhiyong Du et al.

Summary: This study reveals the impact of LDLR genotypes on the metabolome of HoFH patients. Patients carrying one or two null mutations showed significant changes in clinical laboratory lipids and serum metabolites compared to defective/defective mutation carriers. The findings suggest that these altered metabolites may serve as potential targets to mitigate the deleterious impact of LDLR mutations on HoFH.

ISCIENCE (2022)

Article Endocrinology & Metabolism

Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants

Chandna Vasandani et al.

Summary: By comparing the differences between FPLD3 and FPLD2, the study found that patients with FPLD3 have milder lipodystrophy but more severe metabolic complications, suggesting that the remaining adipose tissue in FPLD3 patients may be dysfunctional or those with mild metabolic disease are underrecognized.

JOURNAL OF THE ENDOCRINE SOCIETY (2022)

Review Cardiac & Cardiovascular Systems

Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies

Thorsten Kessler et al.

Summary: Many cardiovascular diseases have a strong genetic component, with large-scale genetic studies identifying genomic loci that influence the risk of specific diseases. While most candidate genes at these loci are not traditionally associated with disease risk factors, experimental research is uncovering novel and unexpected mechanisms. Genome-wide association studies have already led to the development of new treatments, particularly in lipid metabolism. Additionally, polygenic risk scores may have clinical utility in risk prediction and personalized treatment, especially in lipid metabolism.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Article Biochemistry & Molecular Biology

Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study

David G. Thomas et al.

Summary: The study assessed the pleiotropic effects of lipid trait genetic variants and conducted multivariable Mendelian randomization (MR) analysis in coronary artery disease. Results indicated that 30% of lipid trait genetic variants have effects on metabolic syndrome traits, yet the associations of LDL-C, HDL-C, TGs, BMI, T2D, and SBP with CAD remained independent and robust to adjustment for directional pleiotropy. MR at loci linked to direct effects on HDL-C and TGs suggested specific causal effects of these factors on CAD.

JOURNAL OF LIPID RESEARCH (2021)

Review Biochemistry & Molecular Biology

Recent advances in ABCG5 and ABCG8 variants

Vincent Fong et al.

Summary: ABCG5 and ABCG8 variants play a significant role in human diseases, with recent research showing a higher prevalence than previously thought, especially in patients with hypercholesterolemia. Measuring xenosterol levels to screen for variants and tailoring treatment accordingly may help reduce cardiovascular risk.

CURRENT OPINION IN LIPIDOLOGY (2021)

Review Biochemistry & Molecular Biology

The genetic counselor's role in management of patients with dyslipidemia

Emily E. Brown

Summary: Genetic testing plays a growing role in the diagnosis and management of dyslipidemias, highlighting the importance of access to clinicians with expertise in medical genetics and psychological implications related to testing. Genetic counselors are key members of the healthcare team who can fill the knowledge gap within lipid clinics, providing not only medical information but also emotional support for patients and families dealing with hereditary conditions in an ideal management scenario.

CURRENT OPINION IN LIPIDOLOGY (2021)

Review Peripheral Vascular Disease

Lipoprotein (a) and Hypertension

Natalie C. Ward et al.

Summary: This review provides an overview of the associations between elevated blood pressure and lipoprotein (a), highlighting lipoprotein (a) as an independent causal risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Limited data demonstrate an association between elevated lipoprotein (a) and hypertension, but evidence suggests that measuring lipoprotein (a) levels may be useful in risk stratification, especially in hypertensive patients.

CURRENT HYPERTENSION REPORTS (2021)

Article Biochemistry & Molecular Biology

Lipoprotein metabolism in familial hypercholesterolemia

Kevin Chemello et al.

Summary: Familial hypercholesterolemia is a common genetic disorder characterized by high levels of LDL-C and increased risk of premature cardiovascular events. Research focuses on clinical phenotypes, genetic variants, and therapeutic approaches.

JOURNAL OF LIPID RESEARCH (2021)

Article Multidisciplinary Sciences

A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases

Lars Lind et al.

Summary: The strength of Metabolic Syndrome (MetS) as a risk factor for cardiovascular disease (CVD) decreases with age, including for specific outcomes like myocardial infarction, ischemic stroke, and heart failure. Despite the decline in risk ratio, MetS remains significantly associated with incident CVD in older age groups, suggesting that its presence in the elderly should not be underestimated. Further research through clinical interventional trials may be needed to verify the impact of MetS in older populations.

SCIENTIFIC REPORTS (2021)

Article Biology

Prevalence of ApoB100 rs693 gene polymorphism in metabolic syndrome among female students at King Abdulaziz University

Rana A. Alghamdi et al.

Summary: The study investigated the relationship between ApoB100 rs693 gene polymorphism and metabolic syndrome (MetS) in young female students, finding significant associations with glucose concentration and total cholesterol level. Further research with expanded sample sizes is needed for more conclusive results.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Medicine, Research & Experimental

miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches

Nathan L. Price et al.

Summary: miRNAs are critical regulators of biological processes and therapeutic targets, but misconceptions exist in the scientific community about their functions. This review focuses on miR-33 to highlight advances, hurdles, and new techniques in understanding the specific roles of miRNAs like miR-33.

EMBO MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target

Jennifer Behbodikhah et al.

Summary: Apolipoprotein B plays a crucial role in atherogenic lipoproteins, with two major isoforms: apoB48 and apoB100. ApoB concentration serves as a direct measure of circulating atherogenic lipoproteins, independent of particle cholesterol content, making it a more accurate indicator of cardiovascular risk than total cholesterol or LDL cholesterol.

METABOLITES (2021)

Article Multidisciplinary Sciences

The impact of non-additive genetic associations on age-related complex diseases

Marta Guindo-Martinez et al.

Summary: This study utilized an extensive GWAS strategy called GUIDANCE to improve genotype imputation by using multiple reference panels, including the X chromosome and non-additive models. By applying this methodology, 94 genome-wide associated loci were identified for 22 age-related diseases, with 26 previously unreported loci. The study also revealed that 27.7% of these loci would have been missed if standard imputation strategies with a single reference panel and only testing the additive model were used.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

The relationship between metabolic syndrome and obstructive sleep apnea syndrome: a nationwide population-based study

Do Hyun Kim et al.

Summary: Research found a strong association between MetS and OSAS, with men, increased waist circumference and increased triglyceride levels identified as important risk factors for OSAS.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study

Guqiao Nie et al.

Summary: This study found a significant correlation between TG/HDL-C ratio and metabolic syndrome in the elderly Chinese population. After adjusting, TG/HDL-C ratio was identified as an independent risk factor for metabolic syndrome. A TG/HDL-C ratio of 1.49 was determined as the critical value for a higher risk of metabolic syndrome in the elderly, with optimal specificity and sensitivity.

BMJ OPEN (2021)

Review Peripheral Vascular Disease

The Genetic Basis of Hypertriglyceridemia

German D. Carrasquilla et al.

Summary: Hypertriglyceridemia is a common dyslipidemia associated with an increased risk of cardiovascular disease and pancreatitis. Recent studies have identified over 300 genetic loci associated with triglyceride levels, leading to the understanding that some phenotypes previously attributed to monogenic inheritance may have a polygenic basis. These new genetic discoveries hold promise for the development of more effective triglyceride-lowering treatments and personalized medicine approaches against hypertriglyceridemia.

CURRENT ATHEROSCLEROSIS REPORTS (2021)

Article Biochemistry & Molecular Biology

Lipoprotein Lipase Gene Polymorphisms Are Associated with Myocardial Infarction Risk: A Meta-Analysis

Kunhui He et al.

Summary: The meta-analysis suggests that LPL HindIII and S447X polymorphisms may be protective factors for myocardial infarction, while PvuII is not associated. There are ethnic differences in the response to these polymorphisms, indicating the need for larger case-control studies to confirm the results.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2021)

Review Peripheral Vascular Disease

Current Diagnosis and Management of Tangier Disease

Masahiro Koseki et al.

Summary: Tangier disease is a genetic disorder caused by dysfunctional mutation of the ABCA1 gene, leading to extremely low levels of HDL cholesterol. Common physical signs in patients include orange-colored pharyngeal tonsils and hepatosplenomegaly. The disease is associated with significantly reduced HDL-C levels and an increased risk of premature coronary artery disease.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)

Review Medicine, General & Internal

Genetics of coronary artery disease in the post-GWAS era

Zhifen Chen et al.

Summary: Over the past decade, genome-wide association studies (GWAS) have significantly expanded our understanding of the genetics of coronary artery disease (CAD). These studies have led to unprecedented discoveries in CAD research, from low-frequency variants to polygenic risk, marking a new era in the field.

JOURNAL OF INTERNAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred

Roopa Mehta et al.

Summary: This systematic review shows that LCAT deficiency syndromes are clinically and genetically heterogeneous. There was a significantly greater risk of premature coronary artery disease in fish eye disease compared to familial LCAT deficiency. The LCAT mutations discussed in this article are the only ones reported in the Mexican-Amerindian population.

LIPIDS IN HEALTH AND DISEASE (2021)

Article Public, Environmental & Occupational Health

Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland

Elsi Haverinen et al.

Summary: The study compared four different MetS definitions in the Finnish adult population, finding substantial differences in MetS prevalence and agreements between definitions, with varying prevalence across age groups and components.

ARCHIVES OF PUBLIC HEALTH (2021)

Article Endocrinology & Metabolism

A case of autosomal recessive hypercholesterolemia with a novel mutation in the LDLRAP1 gene

Parisa Nikasa et al.

CLINICAL PEDIATRIC ENDOCRINOLOGY (2021)

Article Biochemistry & Molecular Biology

ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition

Yan Q. Chen et al.

Summary: ApoA5 likely decreases TG by suppressing ANGPTL3/8-mediated LPL inhibition, without having a direct effect on LPL. These findings reveal a novel intersection of ApoA5 and ANGPTL3/8 in the regulation of TG metabolism.

JOURNAL OF LIPID RESEARCH (2021)

Article Geriatrics & Gerontology

Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives

Tom G. Richardson et al.

Summary: Genetically elevated apoB is associated with shorter lifespan in parents, increased risks of heart disease and stroke, and higher risk of diabetes, especially when accounting for LDL cholesterol.

LANCET HEALTHY LONGEVITY (2021)

Article Endocrinology & Metabolism

Association of ADIPOQ rs266729 and rs1501299 gene polymorphisms and circulating adiponectin level with the risk of type 2 diabetes in a population of Iran: a case-control study

Mahrokh Alimi et al.

Summary: The study found that the ADIPOQ rs266729 (SNP-11377 C > G) gene polymorphism is associated with an increased risk of T2D in the Iranian population, while rs1501299 is not significantly associated.

JOURNAL OF DIABETES AND METABOLIC DISORDERS (2021)

Review Biochemistry & Molecular Biology

Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases

Hyung Muk Choi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Medicine, General & Internal

Gut microbiota and metabolic syndrome

Peng-Xu Wang et al.

CHINESE MEDICAL JOURNAL (2020)

Review Medicine, General & Internal

Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes

C. Ling

JOURNAL OF INTERNAL MEDICINE (2020)

Review Oncology

The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus

Sanabil Ali Hassan Ahmed et al.

CLINICAL EPIGENETICS (2020)

Review Endocrinology & Metabolism

Genetics of Hypertriglyceridemia

Jacqueline S. Dron et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Biology

The APOB rs693 polymorphism impacts the lipid profile of Brazilian older adults

E. S. Alves et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2020)

Review Biochemistry & Molecular Biology

The association of the PCSK9 rs562556 polymorphism with serum lipids level: a meta-analysis

Junlan Chuan et al.

LIPIDS IN HEALTH AND DISEASE (2019)

Article Cardiac & Cardiovascular Systems

Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes

Sudong Liu et al.

BMC CARDIOVASCULAR DISORDERS (2019)

Article Medicine, Research & Experimental

Genome-Wide Association Study of the Metabolic Syndrome in UK Biobank

Lars Lind

METABOLIC SYNDROME AND RELATED DISORDERS (2019)

Review Endocrinology & Metabolism

The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism

Anouar Hafiane et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

Article Endocrinology & Metabolism

Metabolic Messengers: adiponectin

Leon G. Straub et al.

NATURE METABOLISM (2019)

Review Peripheral Vascular Disease

The Global Epidemic of the Metabolic Syndrome

Mohammad G. Saklayen

CURRENT HYPERTENSION REPORTS (2018)

Article Biochemistry & Molecular Biology

Association of the APOA1 rs964184 SNP and serum lipid traits in the Chinese Maonan and Han populations

Ling Qiu et al.

LIPIDS IN HEALTH AND DISEASE (2018)

Review Cell Biology

Genetic and microbiome influence on lipid metabolism and dyslipidemia

Maria Luisa Matey-Hernandez et al.

PHYSIOLOGICAL GENOMICS (2018)

Article Immunology

Candidate gene polymorphisms related to lipid metabolism in Asian Indians living in Durban, South Africa

Tanya Maistry et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2018)

Review Biochemistry & Molecular Biology

Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review

C. S. Paththinige et al.

LIPIDS IN HEALTH AND DISEASE (2017)

Article Biochemistry & Molecular Biology

Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis

Caiqin Niu et al.

LIPIDS IN HEALTH AND DISEASE (2017)

Article Endocrinology & Metabolism

The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study

Preethi Mani et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)

Article Cardiac & Cardiovascular Systems

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study

Thijs T. W. van Herpt et al.

CARDIOVASCULAR DIABETOLOGY (2016)

Review Biochemistry & Molecular Biology

Metabolic syndrome: genetic insights into disease pathogenesis

Maen D. Abou Ziki et al.

CURRENT OPINION IN LIPIDOLOGY (2016)

Article Endocrinology & Metabolism

Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial

Wenjie Ma et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Review Pharmacology & Pharmacy

Familial defective apolipoprotein B-100: A review

Lars H. Andersen et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Type III Hyperlipoproteinemia: Still Worth Considering?

Conrad B. Blum

PROGRESS IN CARDIOVASCULAR DISEASES (2016)

Article Biochemistry & Molecular Biology

The Apolipoprotein A1 polymorphisms were associated with decreased risk for metabolic syndrome in Koreans

Young Ree Kim et al.

GENES & GENOMICS (2015)

Article Genetics & Heredity

Relation between ADIPOQ Gene Polymorphisms and Type 2 Diabetes

Zhi-Peng Li et al.

GENES (2015)

Article Cardiac & Cardiovascular Systems

Metabolic syndrome across Europe: Different clusters of risk factors

Angelo Scuteri et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)

Article Hematology

Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia

Zhaoyue Wang et al.

AMERICAN JOURNAL OF HEMATOLOGY (2014)

Review Endocrinology & Metabolism

Genetics of metabolic syndrome

Alena Stancakova et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)

Article Multidisciplinary Sciences

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans

Nicholas J. Timpson et al.

NATURE COMMUNICATIONS (2014)

Article Genetics & Heredity

Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia

Ellen R. A. Thomas et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2013)

Review Biochemistry & Molecular Biology

The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - A clinical update and emerging insights from animal models

Dominic S. Ng

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)

Article Biotechnology & Applied Microbiology

Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families

Salvador Munoz-Barrios et al.

DISEASE MARKERS (2012)

Article Endocrinology & Metabolism

Approach to the Patient with Extremely Low HDL-Cholesterol

Daniel J. Rader et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Endocrinology & Metabolism

A Bivariate Genome-Wide Approach to Metabolic Syndrome STAMPEED Consortium

Aldi T. Kraja et al.

DIABETES (2011)

Article Biochemistry & Molecular Biology

Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome

Cecile M. Povel et al.

LIPIDS IN HEALTH AND DISEASE (2011)

Article Multidisciplinary Sciences

Biological, clinical and population relevance of 95 loci for blood lipids

Tanya M. Teslovich et al.

NATURE (2010)

Article Multidisciplinary Sciences

A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men

Delilah Zabaneh et al.

PLOS ONE (2010)

Article Cardiac & Cardiovascular Systems

The Linosa Study: Epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate

A. Bellia et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)

Article Endocrinology & Metabolism

Genetics of Metabolic Syndrome

Tisha Joy et al.

CURRENT DIABETES REPORTS (2008)

Article Medicine, General & Internal

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

JC Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Cardiac & Cardiovascular Systems

Genetic determinants of the metabolic syndrome

Rebecca L. Pollex et al.

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)

Article Cardiac & Cardiovascular Systems

Genetic contributors toward increased risk for ischemic heart disease

MA Nordlie et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)

Article Hematology

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia

S Eichenbaum-Voline et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Article Peripheral Vascular Disease

Hypoadiponectinemia is an independent risk factor for hypertension

Y Iwashima et al.

HYPERTENSION (2004)

Article Biochemistry & Molecular Biology

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

JT Kao et al.

HUMAN MOLECULAR GENETICS (2003)

Review Public, Environmental & Occupational Health

Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review

JE Eichner et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)

Article Medicine, General & Internal

Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey

ES Ford et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)

Article Multidisciplinary Sciences

Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome

AH Kissebah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)

Article Peripheral Vascular Disease

Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort

G Sass et al.

JOURNAL OF HYPERTENSION (2000)